Could your iPad warn you of dangerous cancer treatment side effects?
NCT ID NCT07403812
Summary
This study is testing a new iPad app called DCog Short. The goal is to see if patients can use the app to self-report early signs of brain-related side effects from their CAR-T cell cancer treatment. Researchers will enroll about 40 adult patients to compare the app's results with standard doctor assessments. The app is not yet approved by the FDA for this use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.